Marie Dutherage - Publications

Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: July 03, 2026

Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world study.

Journal: Journal for immunotherapy of cancer

Published: September 14, 2025

Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 08, 2025

Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metastatic pancreatic adenocarcinoma.

Journal: Clinics and research in hepatology and gastroenterology

Published: January 21, 2025

ctDNA variations according to treatment intensity in first-line metastatic colorectal cancer.

Journal: British journal of cancer

Published: September 23, 2024

Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancer.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 03, 2023

Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.

Journal: British journal of cancer

Published: July 10, 2023

Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study.

Journal: ESMO open

Published: March 13, 2023

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer.

Journal: Frontiers in oncology

Published: June 19, 2022